Genetic Screens for Virulence Factors of Mycobacteria
Genetic Screens for Virulence Factors of Mycobacteria
批准号:
6625742
负责人:
VOLKER BRIKEN
金额:
$25.05万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-01 至 2005-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Mycobacterium tuberculosis (M.tb) infects one-third of the world's
population and claims the lives of two to three million people each year. Its
success is achieved by its ability to persist in the hostile intracellular
environment of infected macrophages. After invasion, M.tb manipulates the
phagocytic pathway of the host cell to inhibit the maturation of the phagosome
into a phagolysosome. In addition, M.tb inhibits the apoptotic response of
infected macrophages. These effects are likely to represent a highly evolved
strategy that is used by M.tb to evade the host immune response. Although some
cellular proteins have been characterized as targets of M.tb, it is currently
unclear which bacterial proteins or lipids mediate the interactions.
The proposed research project aims at filling this gap in our knowledge by
focusing on the identification of proteins or lipids of M.tb that are
implicated in either inhibition of maturation of the bacterial phagosome or
inhibition of the apoptotic response of the host cell. The recent advances in
the genetic manipulations of mycobacteria will be used to randomly mutagenize
green fluorescence protein (GFP)-labeled M.tb and screen for mutants deficient
in inhibiting phagosome maturation using a newly developed FACS-based, high-
throughput assay. In a second approach, Mycobacterium smegmatis, a
nonpathogenic mycobacterium deficient in inhibiting phagosome maturation and
apoptosis of the host cell, will be complemented with M.tb genes and clones
that have gained this capacity will be selected. Identification of M.tb genes
essential for persistence of the pathogen will provide important targets for
the development of new drugs for the treatment of tuberculosis and the
development of new attenuated strains of M.tb that may be used as vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
-
批准号:10619641
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2021
-
负责人:VOLKER BRIKEN
-
依托单位:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
-
批准号:10296451
-
项目类别:
-
资助金额:$62.98万
-
财政年份:2021
-
负责人:VOLKER BRIKEN
-
依托单位:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
-
批准号:10424569
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:VOLKER BRIKEN
-
依托单位:
Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signaling
-
批准号:9901025
-
项目类别:
-
资助金额:$22.78万
-
财政年份:2020
-
负责人:VOLKER BRIKEN
-
依托单位:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
-
批准号:10544327
-
项目类别:
-
资助金额:$61.58万
-
财政年份:2019
-
负责人:VOLKER BRIKEN
-
依托单位:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
-
批准号:10080702
-
项目类别:
-
资助金额:$60.81万
-
财政年份:2019
-
负责人:VOLKER BRIKEN
-
依托单位:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
-
批准号:10322367
-
项目类别:
-
资助金额:$61.58万
-
财政年份:2019
-
负责人:VOLKER BRIKEN
-
依托单位:
Characterization of the ESX-5 secretome and its impact on virulence mechanisms of Mycobacterium tuberculosis
-
批准号:9333513
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2017
-
负责人:VOLKER BRIKEN
-
依托单位:
Inhibition of the host cell AIM2 inflammasome by Mycobacterium tuberculosis
-
批准号:8720174
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2014
-
负责人:VOLKER BRIKEN
-
依托单位:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
-
批准号:9033081
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2013
-
负责人:VOLKER BRIKEN
-
依托单位:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
-
批准号:8842940
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2013
-
负责人:VOLKER BRIKEN
-
依托单位:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
-
批准号:9245629
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2013
-
负责人:VOLKER BRIKEN
-
依托单位:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
-
批准号:8656316
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2013
-
负责人:VOLKER BRIKEN
-
依托单位:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
-
批准号:8505629
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2013
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:8018524
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2008
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:7761229
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2008
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:7463148
-
项目类别:
-
资助金额:$14.38万
-
财政年份:2008
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:8215685
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2008
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:7556372
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2008
-
负责人:VOLKER BRIKEN
-
依托单位:
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
-
批准号:7486528
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:VOLKER BRIKEN
-
依托单位:
国内基金
海外基金
鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
-
批准号:31760442
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2017
-
负责人:许倩
-
依托单位: